Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-6-20
pubmed:abstractText
IL-17 is a proinflammatory cytokine that activates T cells and other immune cells to produce a variety of cytokines, chemokines, and cell adhesion molecules. This cytokine is augmented in the sera and/or tissues of patients with contact dermatitis, asthma, and rheumatoid arthritis. We previously demonstrated that IL-17 is involved in the development of autoimmune arthritis and contact, delayed, and airway hypersensitivity in mice. As the expression of IL-17 is also augmented in multiple sclerosis, we examined the involvement of this cytokine in these diseases using IL-17(-/-) murine disease models. We found that the development of experimental autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis, was significantly suppressed in IL-17(-/-) mice; these animals exhibited delayed onset, reduced maximum severity scores, ameliorated histological changes, and early recovery. T cell sensitization against myelin oligodendrocyte glycoprotein was reduced in IL-17(-/-) mice upon sensitization. The major producer of IL-17 upon treatment with myelin digodendrocyte glycopritein was CD4+ T cells rather than CD8+ T cells, and adoptive transfer of IL-17(-/-) CD4+ T cells inefficiently induced EAE in recipient mice. Notably, IL-17-producing T cells were increased in IFN-gamma(-/-) cells, while IFN-gamma-producing cells were increased in IL-17(-/-) cells, suggesting that IL-17 and IFN-gamma mutually regulate IFN-gamma and IL-17 production. These observations indicate that IL-17 rather than IFN-gamma plays a crucial role in the development of EAE.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
177
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
566-73
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16785554-Adoptive Transfer, pubmed-meshheading:16785554-Amino Acid Sequence, pubmed-meshheading:16785554-Animals, pubmed-meshheading:16785554-Autoantibodies, pubmed-meshheading:16785554-CD4-Positive T-Lymphocytes, pubmed-meshheading:16785554-Cells, Cultured, pubmed-meshheading:16785554-Encephalomyelitis, Autoimmune, Experimental, pubmed-meshheading:16785554-Epitopes, T-Lymphocyte, pubmed-meshheading:16785554-Glycoproteins, pubmed-meshheading:16785554-Interferon-gamma, pubmed-meshheading:16785554-Interleukin-17, pubmed-meshheading:16785554-Lymph Nodes, pubmed-meshheading:16785554-Mice, pubmed-meshheading:16785554-Mice, Inbred C57BL, pubmed-meshheading:16785554-Mice, Knockout, pubmed-meshheading:16785554-Molecular Sequence Data, pubmed-meshheading:16785554-Peptide Fragments, pubmed-meshheading:16785554-Up-Regulation
pubmed:year
2006
pubmed:articleTitle
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
pubmed:affiliation
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't